TDI01

· Beijing Tide Pharmaceutical Co., Ltd

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TDI01, covering 2025-09-26 to 2025-09-26. Get the full timeline:

Most recent: Clinical Trial Update: TDI01 Suspension in the Treatment of Chronic Graft-versus-host Disease (cGVHD)) [Phase 1, Phase 2]